Unacceptable toxicity. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Liver Cells, Cultured Cell Line, Tumor Kidney Cell Line Bone Marrow Neurons Lung

Organisms6

Rats, Sprague-Dawley Rats, Inbred F344 Daphnia Mice, Inbred C57BL Bacillus thuringiensis Rats, Wistar

Diseases39

Nausea Neutropenia Disease Progression Neoplasm Metastasis Lung Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms Thrombocytopenia Neoplasm Recurrence, Local Adenocarcinoma Brain Neoplasms Colorectal Neoplasms Liver Neoplasms Breast Neoplasms Fatigue Recurrence Diarrhea Glioma Bone Neoplasms Postoperative Complications Leukopenia Drug-Related Side Effects and Adverse Reactions Radiation Injuries Drug-Induced Liver Injury Pain Hematologic Diseases Neurotoxicity Syndromes Body Weight Plant Poisoning Stomatitis Abnormalities, Drug-Induced Vomiting Drug Eruptions Disease Models, Animal Gastrointestinal Diseases Drug Overdose Poisoning Mucositis Exanthema

Chemicals and Drugs75

Antineoplastic Agents Deoxycytidine Fluorouracil Camptothecin Niacinamide Phenylurea Compounds Quinazolines Antibodies, Monoclonal, Humanized Taxoids Benzenesulfonates Paclitaxel Organoplatinum Compounds Dacarbazine Leucovorin Cisplatin Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Dithioerythritol Protein Kinase Inhibitors Antibodies, Monoclonal Vinblastine Doxorubicin Thalidomide Carboplatin Drug Combinations Pyridines Reagent Kits, Diagnostic Recombinant Proteins Antidotes Cyclophosphamide Anti-Bacterial Agents Teratogens Water Pollutants, Chemical Etoposide Environmental Pollutants Glutathione Insecticides Methotrexate Antineoplastic Agents, Alkylating Plant Extracts Vincristine Antibiotics, Antineoplastic Acetaminophen Prodrugs Ifosfamide Cadmium Methylmercury Compounds Aluminum Cytochrome P-450 CYP2E1 Neurotoxins Dihydrouracil Dehydrogenase (NADP)Drug Carriers Bacterial Toxins Amyloid beta-Peptides Antioxidants Bleomycin Reactive Oxygen Species L-Lactate Dehydrogenase Topotecan Amifostine Melphalan Herbicides Immunotoxins Xenobiotics Endotoxins Cytarabine Tetrachlorodibenzodioxin Enzyme Inhibitors Liposomes Toxins, Biological Epirubicin Carmustine Prednisone Organophosphorus Compounds Thiazoles

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Disease-Free Survival Maximum Tolerated Dose Infusions, Intravenous Administration, Oral Survival Rate Kaplan-Meier Estimate Toxicity Tests Neoplasm Staging Survival Analysis Salvage Therapy Follow-Up Studies Toxicity Tests, Acute Drug Evaluation Combined Modality Therapy Lethal Dose 50 Evaluation Studies as Topic Retrospective Studies Toxicity Tests, Chronic Clinical Trials as Topic Reproducibility of Results Radiotherapy Dosage Prospective Studies Feasibility Studies Treatment Failure Remission Induction Risk Assessment Area Under Curve False Positive Reactions Drug Therapy, Combination Random Allocation Sensitivity and Specificity Reagent Kits, Diagnostic No-Observed-Adverse-Effect Level Pilot Projects Prognosis Clinical Protocols False Negative Reactions Research Design Double-Blind Method Observer Variation Reference Standards Statistics as Topic Questionnaires Randomized Controlled Trials as Topic Risk Factors Severity of Illness Index Toxicity Tests, Subchronic Patient Selection Equipment Design Analysis of Variance Cohort Studies Reoperation Interviews as Topic Tomography, X-Ray Computed Drug Evaluation, Preclinical Animal Testing Alternatives Predictive Value of Tests Radiotherapy Organ Size Toxicity Tests, Subacute Dose Fractionation Body Weight Cross-Sectional Studies Radiotherapy, Conformal Injections, Intravenous Radioimmunotherapy Clinical Trials, Phase I as Topic Drug Carriers Radiotherapy, Intensity-Modulated Disease Models, Animal Drug Delivery Systems Drug Overdose Chemotherapy, Adjuvant Mutagenicity Tests Hematologic Tests Injections, Intraperitoneal Metabolic Clearance Rate Chemoradiotherapy Dose-Response Relationship, Radiation Blood Cell Count

Psychiatry and Psychology6

Personal Autonomy Attitude to Health Attitude of Health Personnel Physician-Patient Relations Pain Decision Making

Phenomena and Processes29

Maximum Tolerated Dose Dose-Response Relationship, Drug Drug Resistance, Neoplasm Time Factors Lethal Dose 50 Area Under Curve Sensitivity and Specificity Pregnancy No-Observed-Adverse-Effect Level Cell Survival Algorithms Pain Drug Interactions Organ Size Body Weight Oxidative Stress Apoptosis Tissue Distribution Drug Synergism Cell Death Biotransformation Metabolic Detoxication, Drug Particle Size Mutation Molecular Structure Structure-Activity Relationship Metabolic Clearance Rate Dose-Response Relationship, Radiation Blood Cell Count

Disciplines and Occupations5

Research Design Toxicology Statistics as Topic Outcome Assessment (Health Care)Toxicogenetics

Anthropology, Education, Sociology and Social Phenomena4

Patient Advocacy Personal Autonomy Informed Consent Quality of Life

Technology, Industry, Agriculture4

Quality Control Nanoparticles Metal Nanoparticles Liposomes

Humanities4

Beneficence Ethics, Medical Personal Autonomy Quality of Life

Information Science7

Survival Rate Algorithms Questionnaires Interviews as Topic Computer Simulation Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Named Groups1

Infant, Newborn

Health Care48

Treatment Outcome Disease-Free Survival Survival Rate Kaplan-Meier Estimate Survival Analysis Follow-Up Studies Ethics, Medical Evaluation Studies as Topic Patient Advocacy Retrospective Studies Clinical Trials as Topic Reproducibility of Results Prospective Studies Laboratories Feasibility Studies Treatment Failure Personal Autonomy Risk Assessment Area Under Curve Random Allocation Sensitivity and Specificity Pilot Projects Informed Consent Practice Guidelines as Topic Clinical Protocols Medical Audit Quality Assurance, Health Care Double-Blind Method Observer Variation Statistics as Topic Questionnaires Randomized Controlled Trials as Topic Patient Satisfaction Radiation Injuries Risk Factors Severity of Illness Index Attitude to Health Patient Selection Attitude of Health Personnel Analysis of Variance Physician-Patient Relations Cohort Studies Interviews as Topic Predictive Value of Tests Outcome Assessment (Health Care)Cross-Sectional Studies Clinical Trials, Phase I as Topic Dose-Response Relationship, Radiation

Geographicals4

United States Great Britain Canada England

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Antineoplastic Agents Deoxycytidine Disease-Free Survival Maximum Tolerated Dose Infusions, Intravenous Fluorouracil Camptothecin Administration, Oral Nausea Dose-Response Relationship, Drug Niacinamide Phenylurea Compounds Quinazolines Neutropenia Survival Rate Antibodies, Monoclonal, Humanized Taxoids Benzenesulfonates Paclitaxel Disease Progression Organoplatinum Compounds Neoplasm Metastasis Lung Neoplasms Dacarbazine Leucovorin Cisplatin Kaplan-Meier Estimate Toxicity Tests Carcinoma, Non-Small-Cell Lung Neoplasms Thrombocytopenia Neoplasm Recurrence, Local Neoplasm Staging Antineoplastic Agents, Phytogenic Survival Analysis Antimetabolites, Antineoplastic Salvage Therapy Adenocarcinoma Brain Neoplasms Drug Resistance, Neoplasm Dithioerythritol Protein Kinase Inhibitors Colorectal Neoplasms Antibodies, Monoclonal Follow-Up Studies Liver Neoplasms Toxicity Tests, Acute Breast Neoplasms Quality Control Beneficence Time Factors Ethics, Medical Drug Evaluation Combined Modality Therapy Lethal Dose 50 Vinblastine Doxorubicin Evaluation Studies as Topic Patient Advocacy Retrospective Studies Toxicity Tests, Chronic Clinical Trials as Topic Thalidomide Reproducibility of Results Radiotherapy Dosage Prospective Studies Laboratories Feasibility Studies Treatment Failure Carboplatin Personal Autonomy Remission Induction Risk Assessment Fatigue Recurrence Area Under Curve Drug Combinations False Positive Reactions Drug Therapy, Combination Diarrhea Random Allocation Pyridines Sensitivity and Specificity Pregnancy Reagent Kits, Diagnostic No-Observed-Adverse-Effect Level Pilot Projects Cell Survival Informed Consent Practice Guidelines as Topic Prognosis Clinical Protocols False Negative Reactions Glioma Medical Audit Bone Neoplasms United States

No FAQ available that match "unacceptable toxicity"